View Information Collection Request (ICR) Package
Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0910-0599
ICR Reference No:
201707-0910-007
Status:
Historical Active
Previous ICR Reference No:
201406-0910-015
Agency/Subagency:
HHS/FDA
Agency Tracking No:
CFSAN
Title:
Cosmetic Labeling Regulations
Type of Information Collection:
Extension without change of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
09/20/2017
Retrieve Notice of Action (NOA)
Date Received in OIRA:
08/17/2017
Terms of Clearance:
Inventory as of this Action
Requested
Previously Approved
Expiration Date
09/30/2020
36 Months From Approved
09/30/2017
Responses
141,174
0
141,174
Time Burden (Hours)
141,174
0
141,174
Cost Burden (Dollars)
0
0
0
Abstract:
This information collection requires that cosmetic labeling include a list of ingredients in descending order of predominance; a statement of the identity of the product; the establishment's name and place of business; and the net quantity of contents. Respondents to the information collection are manufacturers, packers, and distributors of cosmetic products.
Authorizing Statute(s):
US Code:
21 USC 301 et seq.
Name of Law: FFDCA
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
82 FR 23576
05/23/2017
30-day Notice:
Federal Register Citation:
Citation Date:
82 FR 37100
08/08/2017
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
1
IC Title
Form No.
Form Name
21 CFR 701.11 - Third Party Disclosure: Labeling Requirement , Principal Display Panel of Cosmetic Product Must Bear a Statement of The Identity of The Product
21 CFR 701.12 Third Party Disclosure - Labeling Requirement - Label of a Cosmetic Product Must Specify The Name and Place of Business of the Manufacturer , Packer or Distributor
21 CFR 701.13 Third Party Disclosure- Labeling requirement : Label odf A cosmetic Product Must Declare the Net Quantity Contents of the Product
Cosmetic Labeling Regulations
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
141,174
141,174
0
0
0
0
Annual Time Burden (Hours)
141,174
141,174
0
0
0
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
No
Burden Increase Due to:
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
This information collection remains unchanged. At the same time, we have revised the IC list appearing at www.reginfo.gov by consolidating the previously itemized regulatory provisions. We believe this will assist the reader by more easily identifying the summary of cumulative fluctuations for the collection. At the same time, readers may still view estimated burden associated with individual provisions by referring to the agency’s 60-day and 30-day notices and in the burden tables found in Q.12: Estimates of Annualized Burden Hours and Costs of this supporting statement.
Annual Cost to Federal Government:
$953,472
Does this IC contain surveys, censuses, or employ statistical methods?
No
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
No
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
Uncollected
Agency Contact:
Ila Mizrachi 301 796-7726 ila.mizrachi@fda.hhs.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
08/17/2017
Something went wrong when downloading this file. If you have any questions, please send an email to risc@gsa.gov.